Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Tabe, Yoko  [Clear All Filters]
Journal Article
Yokoo M, Kubota Y, Motoyama K, Higashi T, Taniyoshi M, Tokumaru H, Nishiyama R, Tabe Y, Mochinaga S, Sato A, et al. 2-Hydroxypropyl-β-Cyclodextrin Acts as a Novel Anticancer Agent. PLoS One. 2015;10(11):e0141946.
Maki R, Tabe Y, Yamamoto T, Takemura H, Sawada T, Esaki T, Higuchi M, Misawa S, Miyake K, Miida T, et al. Accuracy study of a novel alternate method measuring erythrocyte sedimentation rate for prototype hematology analyzer Celltac α. Int J Lab Hematol. 2021.
Yatsenko T, Rios R, Nogueira T, Salama Y, Takahashi S, Tabe Y, Naito T, Takahashi K, Hattori K, Heissig B. Corrigendum: Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19. Front Immunol. 2024;15:1390698.
Tsuchiya K, Tabe Y, Ai T, Ohkawa T, Usui K, Yuri M, Misawa S, Morishita S, Takaku T, Kakimoto A, et al. Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes. PLoS One. 2018;13(10):e0202429.
Saito K, Zhang Q, Yang H, Yamatani K, Ai T, Ruvolo V, Baran N, Cai T, Ma H, Jacamo R, et al. Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition. Blood Adv. 2021.
Yamatani K, Tabe Y, Ai T, Kimura K, Takemura H, Tsuchiya K, Yang H, Konishi A, Uchihashi K, Horii T, et al. Performance evaluation of the Sysmex DI-60 overview application for tumor cell detection in body fluid samples. Int J Lab Hematol. 2019.